Forte Biosciences CEO and CFO Double Down on Shares, Eyes Possible Catalyst Ahead of Q2 Results
Forte Biosciences insider buying spree signals confidence ahead of possible catalyst, offering a cautious yet optimistic view for investors.
3 minutes to read